Review





Similar Products

anti-aβ antibody clone 6f/3d  (Novocastra)
90
Novocastra anti-aβ antibody clone 6f/3d
Anti Aβ Antibody Clone 6f/3d, supplied by Novocastra, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-aβ antibody clone 6f/3d/product/Novocastra
Average 90 stars, based on 1 article reviews
anti-aβ antibody clone 6f/3d - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
aβ 6f/3d antibody  (Novocastra)
90
Novocastra aβ 6f/3d antibody
Aβ 6f/3d Antibody, supplied by Novocastra, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aβ 6f/3d antibody/product/Novocastra
Average 90 stars, based on 1 article reviews
aβ 6f/3d antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
antibodies for aβ 6f/3d  (Novocastra)
90
Novocastra antibodies for aβ 6f/3d
An overview of the methodology. A, We used the APART‐QSM method to simultaneously distinguish dia‐ and paramagnetic susceptibility sources, exploring <t>Aβ</t> aggregation and brain iron levels in ex vivo human brains from individuals with AD and healthy controls. B, The imaging results were compared to the Aβ immunohistochemistry, and <t>Perls/DAB</t> <t>staining.</t> The stained slice in the figure is from AD02. The scale bar in the zoomed‐in stained sections represent 200 μm. C, Regional dia‐ and paramagnetic susceptibility values were extracted using MMP Atlas, difference between AD and HC were calculated. D, We examined the gene expression in the same brain regions using transcriptomic data obtained from the Allen Human Brain Atlas. Using PLS regression and gene ontological tools, we explored the biological processes associated with this transcriptomic profile. Aβ, amyloid beta; AD, Alzheimer's disease; APART‐QSM, the iterative magnetic susceptibility sources separation; DAB, diaminobenzidine; HC, healthy control; MMP, Multi‐Model Parcellation; MRI, magnetic resonance imaging; PLS, partial least squares.
Antibodies For Aβ 6f/3d, supplied by Novocastra, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies for aβ 6f/3d/product/Novocastra
Average 90 stars, based on 1 article reviews
antibodies for aβ 6f/3d - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mouse monoclonal anti-aβ antibody 6f/3d  (Agilent technologies)
90
Agilent technologies mouse monoclonal anti-aβ antibody 6f/3d
An overview of the methodology. A, We used the APART‐QSM method to simultaneously distinguish dia‐ and paramagnetic susceptibility sources, exploring <t>Aβ</t> aggregation and brain iron levels in ex vivo human brains from individuals with AD and healthy controls. B, The imaging results were compared to the Aβ immunohistochemistry, and <t>Perls/DAB</t> <t>staining.</t> The stained slice in the figure is from AD02. The scale bar in the zoomed‐in stained sections represent 200 μm. C, Regional dia‐ and paramagnetic susceptibility values were extracted using MMP Atlas, difference between AD and HC were calculated. D, We examined the gene expression in the same brain regions using transcriptomic data obtained from the Allen Human Brain Atlas. Using PLS regression and gene ontological tools, we explored the biological processes associated with this transcriptomic profile. Aβ, amyloid beta; AD, Alzheimer's disease; APART‐QSM, the iterative magnetic susceptibility sources separation; DAB, diaminobenzidine; HC, healthy control; MMP, Multi‐Model Parcellation; MRI, magnetic resonance imaging; PLS, partial least squares.
Mouse Monoclonal Anti Aβ Antibody 6f/3d, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti-aβ antibody 6f/3d/product/Agilent technologies
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-aβ antibody 6f/3d - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
monoclonal aβ antibody, 6f/3d  (Agilent technologies)
90
Agilent technologies monoclonal aβ antibody, 6f/3d
An overview of the methodology. A, We used the APART‐QSM method to simultaneously distinguish dia‐ and paramagnetic susceptibility sources, exploring <t>Aβ</t> aggregation and brain iron levels in ex vivo human brains from individuals with AD and healthy controls. B, The imaging results were compared to the Aβ immunohistochemistry, and <t>Perls/DAB</t> <t>staining.</t> The stained slice in the figure is from AD02. The scale bar in the zoomed‐in stained sections represent 200 μm. C, Regional dia‐ and paramagnetic susceptibility values were extracted using MMP Atlas, difference between AD and HC were calculated. D, We examined the gene expression in the same brain regions using transcriptomic data obtained from the Allen Human Brain Atlas. Using PLS regression and gene ontological tools, we explored the biological processes associated with this transcriptomic profile. Aβ, amyloid beta; AD, Alzheimer's disease; APART‐QSM, the iterative magnetic susceptibility sources separation; DAB, diaminobenzidine; HC, healthy control; MMP, Multi‐Model Parcellation; MRI, magnetic resonance imaging; PLS, partial least squares.
Monoclonal Aβ Antibody, 6f/3d, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal aβ antibody, 6f/3d/product/Agilent technologies
Average 90 stars, based on 1 article reviews
monoclonal aβ antibody, 6f/3d - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
aβ 6f/3d, mouse monoclonal  (Agilent technologies)
90
Agilent technologies aβ 6f/3d, mouse monoclonal
An overview of the methodology. A, We used the APART‐QSM method to simultaneously distinguish dia‐ and paramagnetic susceptibility sources, exploring <t>Aβ</t> aggregation and brain iron levels in ex vivo human brains from individuals with AD and healthy controls. B, The imaging results were compared to the Aβ immunohistochemistry, and <t>Perls/DAB</t> <t>staining.</t> The stained slice in the figure is from AD02. The scale bar in the zoomed‐in stained sections represent 200 μm. C, Regional dia‐ and paramagnetic susceptibility values were extracted using MMP Atlas, difference between AD and HC were calculated. D, We examined the gene expression in the same brain regions using transcriptomic data obtained from the Allen Human Brain Atlas. Using PLS regression and gene ontological tools, we explored the biological processes associated with this transcriptomic profile. Aβ, amyloid beta; AD, Alzheimer's disease; APART‐QSM, the iterative magnetic susceptibility sources separation; DAB, diaminobenzidine; HC, healthy control; MMP, Multi‐Model Parcellation; MRI, magnetic resonance imaging; PLS, partial least squares.
Aβ 6f/3d, Mouse Monoclonal, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aβ 6f/3d, mouse monoclonal/product/Agilent technologies
Average 90 stars, based on 1 article reviews
aβ 6f/3d, mouse monoclonal - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
aβ (6f/3d  (Agilent technologies)
90
Agilent technologies aβ (6f/3d
An overview of the methodology. A, We used the APART‐QSM method to simultaneously distinguish dia‐ and paramagnetic susceptibility sources, exploring <t>Aβ</t> aggregation and brain iron levels in ex vivo human brains from individuals with AD and healthy controls. B, The imaging results were compared to the Aβ immunohistochemistry, and <t>Perls/DAB</t> <t>staining.</t> The stained slice in the figure is from AD02. The scale bar in the zoomed‐in stained sections represent 200 μm. C, Regional dia‐ and paramagnetic susceptibility values were extracted using MMP Atlas, difference between AD and HC were calculated. D, We examined the gene expression in the same brain regions using transcriptomic data obtained from the Allen Human Brain Atlas. Using PLS regression and gene ontological tools, we explored the biological processes associated with this transcriptomic profile. Aβ, amyloid beta; AD, Alzheimer's disease; APART‐QSM, the iterative magnetic susceptibility sources separation; DAB, diaminobenzidine; HC, healthy control; MMP, Multi‐Model Parcellation; MRI, magnetic resonance imaging; PLS, partial least squares.
Aβ (6f/3d, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aβ (6f/3d/product/Agilent technologies
Average 90 stars, based on 1 article reviews
aβ (6f/3d - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


An overview of the methodology. A, We used the APART‐QSM method to simultaneously distinguish dia‐ and paramagnetic susceptibility sources, exploring Aβ aggregation and brain iron levels in ex vivo human brains from individuals with AD and healthy controls. B, The imaging results were compared to the Aβ immunohistochemistry, and Perls/DAB staining. The stained slice in the figure is from AD02. The scale bar in the zoomed‐in stained sections represent 200 μm. C, Regional dia‐ and paramagnetic susceptibility values were extracted using MMP Atlas, difference between AD and HC were calculated. D, We examined the gene expression in the same brain regions using transcriptomic data obtained from the Allen Human Brain Atlas. Using PLS regression and gene ontological tools, we explored the biological processes associated with this transcriptomic profile. Aβ, amyloid beta; AD, Alzheimer's disease; APART‐QSM, the iterative magnetic susceptibility sources separation; DAB, diaminobenzidine; HC, healthy control; MMP, Multi‐Model Parcellation; MRI, magnetic resonance imaging; PLS, partial least squares.

Journal: Alzheimer's & Dementia

Article Title: Distinct regional vulnerability to Aβ and iron accumulation in post mortem AD brains

doi: 10.1002/alz.14188

Figure Lengend Snippet: An overview of the methodology. A, We used the APART‐QSM method to simultaneously distinguish dia‐ and paramagnetic susceptibility sources, exploring Aβ aggregation and brain iron levels in ex vivo human brains from individuals with AD and healthy controls. B, The imaging results were compared to the Aβ immunohistochemistry, and Perls/DAB staining. The stained slice in the figure is from AD02. The scale bar in the zoomed‐in stained sections represent 200 μm. C, Regional dia‐ and paramagnetic susceptibility values were extracted using MMP Atlas, difference between AD and HC were calculated. D, We examined the gene expression in the same brain regions using transcriptomic data obtained from the Allen Human Brain Atlas. Using PLS regression and gene ontological tools, we explored the biological processes associated with this transcriptomic profile. Aβ, amyloid beta; AD, Alzheimer's disease; APART‐QSM, the iterative magnetic susceptibility sources separation; DAB, diaminobenzidine; HC, healthy control; MMP, Multi‐Model Parcellation; MRI, magnetic resonance imaging; PLS, partial least squares.

Article Snippet: In this study, IHC staining was performed using antibodies for Aβ (6F/3D; 1:10; Novocastra Vector Labs) and phosphorylated tau (AT8; 1:1000; Endogen), to validate the accuracy of the estimated diamagnetic susceptibility for measuring Aβ aggregation.

Techniques: Ex Vivo, Imaging, Immunohistochemistry, Staining, Gene Expression, Control, Magnetic Resonance Imaging

Correlation between regional APART‐QSM and histological measures. The linear correlation between (A) the absolute value of diamagnetic susceptibility and Aβ‐positive area (%) computed from Aβ‐IHC staining of sections, (B) the paramagnetic susceptibility and iron‐positive area (%) computed from Perls/DAB in various brain regions, including MFG, EC, HP, PHA, IPL. The AD1 samples are represented by the darker color, while the AD2 samples are represented by the lighter color. The solid line represents the linear fitting, and the dotted line represents the 95% confidence bounds. B–D, Aβ‐stained section of PHG from AD2, HP from AD2, HP from AD1. F–H, Iron‐stained section of HP from AD2, ED from AD1, PHA from AD1. Aβ, amyloid beta; AD, Alzheimer's disease; APART‐QSM, the iterative magnetic susceptibility sources separation; DAB, diaminobenzidine; EC, entorhinal cortex; HC, healthy control; HP, hippocampus; IHC, immunohistochemistry; IPL, inferior parietal lobe; MFG, middle frontal gyrus; PHA, para‐hippocampal gyrus.

Journal: Alzheimer's & Dementia

Article Title: Distinct regional vulnerability to Aβ and iron accumulation in post mortem AD brains

doi: 10.1002/alz.14188

Figure Lengend Snippet: Correlation between regional APART‐QSM and histological measures. The linear correlation between (A) the absolute value of diamagnetic susceptibility and Aβ‐positive area (%) computed from Aβ‐IHC staining of sections, (B) the paramagnetic susceptibility and iron‐positive area (%) computed from Perls/DAB in various brain regions, including MFG, EC, HP, PHA, IPL. The AD1 samples are represented by the darker color, while the AD2 samples are represented by the lighter color. The solid line represents the linear fitting, and the dotted line represents the 95% confidence bounds. B–D, Aβ‐stained section of PHG from AD2, HP from AD2, HP from AD1. F–H, Iron‐stained section of HP from AD2, ED from AD1, PHA from AD1. Aβ, amyloid beta; AD, Alzheimer's disease; APART‐QSM, the iterative magnetic susceptibility sources separation; DAB, diaminobenzidine; EC, entorhinal cortex; HC, healthy control; HP, hippocampus; IHC, immunohistochemistry; IPL, inferior parietal lobe; MFG, middle frontal gyrus; PHA, para‐hippocampal gyrus.

Article Snippet: In this study, IHC staining was performed using antibodies for Aβ (6F/3D; 1:10; Novocastra Vector Labs) and phosphorylated tau (AT8; 1:1000; Endogen), to validate the accuracy of the estimated diamagnetic susceptibility for measuring Aβ aggregation.

Techniques: Immunohistochemistry, Staining, Control